We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
33 result(s) found, displaying 11 to 20
-
Prescription medicine registrationActive ingredients: mercaptamine (cysteamine).
-
QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial (321016)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial. -
-
Designation or determinationOrphan drug
-
Prescription medicine registrationActive ingredients: chlormethine hydrochloride.
-
Designation or determinationOrphan drug
-
Designation or determinationOrphan drug
-
Designation or determinationOrphan drug
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PEDEA ibuprofen 10 mg/2 mL solution for intravenous infusion 2 mL glass ampoule.